Loading...
This record has been deleted. Since it is linked to a published record, it is available here for reference purposes only.
Click here to view the deleted recordThis document has been updated. This is not the latest published version. Click here to view the latest version of the record.
Internationally Recognized Certificates of Compliance
(IRCC)
last updated: 17 Sep 2019
ABSCH-IRCC-IN-247526-1
Competent National Authority:National Biodiversity Authority ()5th Floor, TICEL Biopark, CSIR Road, TaramaniChennai, Tamilnadu
600 113, IndiaPhone: +91 44 2254 2777,Fax: +91 44 2254 1200,Website: http://www.nbaindia.org,
India/NBA/Appl/9/130-A32
Application in Form-III for seeking approval for the invention on "Synthesis and antibacterial activity of novel erythromycin derivatives" for obtaining IP Rights in India
Indian Patent Application Number: 0525/DEL/2006 Date of Filing: 2007-02-02
23 Dec 2016
Yes
Competent National Authority:National Biodiversity Authority ()5th Floor, TICEL Biopark, CSIR Road, TaramaniChennai, Tamilnadu
600 113, IndiaPhone: +91 44 2254 2777,Fax: +91 44 2254 1200,Website: http://www.nbaindia.org,
Confidential information
-
Organization:
Council of Scientific and Industrial Research
(CSIR)
|
ABSCH-CON-IN-239442-1
This linked record has been deleted.
Organization:Council of Scientific and Industrial Research (CSIR)Academic or research institute3rd Floor, NISCAIR Building, 14, Satsang Vihar Marg, Special Institutional Area,New Delhi, New Delhi
110067, IndiaPhone: +91 1126962560, +91 26965613,Fax: +91 26968819,Email: head.ipu@niscair.res.in,Website:
Confidential information
Yes
1. The user shall notify the NBA within six months from the date of grant of IPR.
2.The user shall pay 2% of the net Revenue (upfront/ licensing/ assignment/ royalty fee) annually during the term of this agreement.
3. The user shall inform the NBA about any commercialization made on the IP Rights granted.
4. The user shall submit the half-yearly report to NBA as per the terms and conditions agreed upon.
For obtaining IP Rights on the Invention “Synthesis and antibacterial activity of novel erythromycin derivatives" in India
Confidential information
- Commercial
In case the user assigns or transfers the IPR in whole or in part to any person, whether voluntarily or involuntarily, the user undertakes to attach this agreement as an appendix to the assignment instrument, which shall be binding upon such person.
| Unique identifier | Status | Date |
|---|---|---|
| ABSCH-IRCC-IN-247526-1 |
REVOKED
OLD VERSION
PUBLISHED
DELETED
|
Sujata Arora (sujata@nic.in)
17 Sep 2019 10:44 on 17 Sep 2019 10:44
|
